Literature DB >> 24006006

Diagnostic rates differ on the basis of the number of read days with the use of the InPouch culture system for Trichomonas vaginalis screening.

Charles A Rivers1, Christina A Muzny, Jane R Schwebke.   

Abstract

The InPouch Trichomonas vaginalis test is the gold standard for clinical culture for Trichomonas vaginalis screening. The current package insert recommends an examination period of 3 days. After review of 2,499 InPouch tests spanning 13 years, we observed that examination up to 3 days will detect only 82.8% (95% confidence interval [CI], 79.0% to 86.2%) of positive specimens.

Entities:  

Mesh：

Year:  2013        PMID： 24006006      PMCID： PMC3889787          DOI： 10.1128/JCM.02006-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

2.  A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.

Authors:  W Wiese; S R Patel; S C Patel; C A Ohl; C A Estrada
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

3.  Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.

Authors:  Melinda B Nye; Jane R Schwebke; Barbara A Body
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

4.  Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling.

Authors:  Sami L Gottlieb; John M Douglas; Mark Foster; D Scott Schmid; Daniel R Newman; Anna E Baron; Gail Bolan; Michael Iatesta; C Kevin Malotte; Jonathan Zenilman; Martin Fishbein; Thomas A Peterman; Mary L Kamb
Journal:  J Infect Dis       Date:  2004-08-05       Impact factor: 5.226

Review 5.  Trichomoniasis and HIV interactions: a review.

Authors:  Patricia Kissinger; Alys Adamski
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

6.  Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women.

Authors:  Marcia L Shew; J Dennis Fortenberry; Wanzhu Tu; Beth E Juliar; Byron E Batteiger; Brahim Qadadri; Darron R Brown
Journal:  Arch Pediatr Adolesc Med       Date:  2006-02

7.  Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.

Authors:  Jennifer R Stark; Gregory Judson; John F Alderete; Vasanthakrishna Mundodi; Ashwini S Kucknoor; Edward L Giovannucci; Elizabeth A Platz; Siobhan Sutcliffe; Katja Fall; Tobias Kurth; Jing Ma; Meir J Stampfer; Lorelei A Mucci
Journal:  J Natl Cancer Inst       Date:  2009-09-09       Impact factor: 13.506
  7 in total
  4 in total

1.  Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.

Authors:  Jane R Schwebke; C A Gaydos; T Davis; J Marrazzo; D Furgerson; S N Taylor; B Smith; L H Bachmann; R Ackerman; T Spurrell; D Ferris; C A Burnham; H Reno; J Lebed; D Eisenberg; P Kerndt; S Philip; J Jordan; N Quigley
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

2.  Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.

Authors:  Jane R Schwebke; Charlotte A Gaydos; Paul Nyirjesy; Sonia Paradis; Salma Kodsi; Charles K Cooper
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

Review 3.  Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.

Authors:  Olivia T Van Gerwen; Christina A Muzny
Journal:  F1000Res       Date:  2019-09-20

4.  Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.

Authors:  Christina A Muzny; Jane R Schwebke; Paul Nyirjesy; Gregory Kaufman; Leandro A Mena; Gweneth B Lazenby; Olivia T Van Gerwen; Keonte J Graves; Janeen Arbuckle; Belvia A Carter; Connette P McMahon; Scott Eder; Jackie Shaw; Brajesh Pandey; Steven E Chavoustie
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.